Physician

Christopher Vlasek

According to 2025 Medicare claims, Christopher Vlasek (NPI: 1518351089) practices family practice in the Carson City, NV market, with the plurality of this provider's patient population coming from Carson City, NV. This provider's primary affiliated billing organization is CARSON TAHOE PHYSICIAN CLINICS (NPI: 1023265717; TIN: 02-0566741) and primary practice location at 89703-0001. Vlasek is affiliated with the Silver State ACO LLC (ACO ID: A2251), participating under the MSSP model.

Vlasek's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 703 traditional Medicare patients, billed 3,526 HCPCS/CPT codes, and received $216,977 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 10,642 prescription claims across 1,032 beneficiaries totaling $1,315,595 in drug costs, led by Trulicity (Dulaglutide). DME data shows 63 claims. Open Payments data shows 19 records totaling $360. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $37,893 to $216,977. Similarly, Part D prescription costs have moved sharply higher in recent years, from $5,969 to $1,315,595. In contrast, DME billing represents a smaller volume and rose steadily, from $641 to $5,244.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	245	541	$37,893
2019	700	1,745	$119,017
2020	632	1,553	$104,602
2021	603	1,525	$120,021
2022	594	1,685	$126,831
2023	665	2,521	$170,457
2024	703	3,526	$216,977

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	37	138	$5,969
2017	73	559	$44,648
2018	229	1,283	$86,478
2019	616	5,551	$461,899
2020	634	7,008	$616,682
2021	652	7,252	$664,198
2022	706	7,824	$729,863
2023	829	8,664	$1,016,339
2024	1,032	10,642	$1,315,595

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	56	$2,081
2018	N/R	107	$3,563
2019	27	81	$1,897
2020	33	105	$1,139
2021	19	85	$2,527
2022	14	107	$6,720
2023	N/R	149	$9,651
2024	N/R	63	$2,751

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	315	315	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	574	968	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	189	223	$59
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	157	1,068	$47
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	333	424	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trulicity	Dulaglutide	83	5,136	$169,653
Farxiga	Dapagliflozin Propanediol	107	8,550	$156,172
Eliquis	Apixaban	113	8,070	$152,841
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	116	6,990	$144,612
Jardiance	Empagliflozin	75	6,570	$125,021

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	34	$2,375
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	18	$214
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	11	$162

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$360	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Vlasek?

Tedicare shows public-source Medicare data for Christopher Vlasek (NPI 1518351089), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Vlasek have ACO affiliation data?

Christopher Vlasek is shown with ACO affiliation data for Silver State ACO LLC (MSSP, ACO ID A2251).

What billing organization is linked to Christopher Vlasek?

Christopher Vlasek is linked to CARSON TAHOE PHYSICIAN CLINICS (billing NPI 1023265717) in the available physician profile data.

Does Christopher Vlasek have Open Payments data?

Christopher Vlasek has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.